Summary
Boston Scientific Corporation (BSX) has filed an 8-K report on February 2, 2022, primarily to furnish their press release announcing financial results for the fourth quarter and full year ended December 31, 2021. This filing serves as the official notification of these results, although the specific financial details are contained within the accompanying press release (Exhibit 99.1), which is not deemed "filed" for regulatory purposes under Section 18 of the Exchange Act. Investors should refer to Exhibit 99.1 for a comprehensive understanding of the company's performance, including key metrics and financial condition as of year-end 2021. The nature of this 8-K filing indicates that the core financial performance information for the period will be found in the press release itself. Therefore, any analysis of BSX's operational results, profitability, revenue streams, or forward-looking statements would require a detailed review of the furnished press release. The filing itself is a procedural step to make these results publicly available.
Key Highlights
- 1Boston Scientific Corp (BSX) announced its Q4 and full-year 2021 financial results via a press release furnished with this 8-K filing.
- 2The 8-K was filed on February 2, 2022, with the event date being February 1, 2022.
- 3The primary purpose of the 8-K is to provide public access to the company's earnings announcement.
- 4The press release (Exhibit 99.1) contains the detailed financial results and operational performance for the period.
- 5Information furnished under Item 2.02 of this 8-K, including the press release, is not considered 'filed' for Section 18 of the Exchange Act liability.
- 6Investors need to consult Exhibit 99.1 for specific financial data and performance analysis.
- 7The filing includes a Cover Page Interactive Data File (XBRL) for enhanced data accessibility.